Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
2秒前
2秒前
彭于晏的应助被是多多呀采纳,获得10
2秒前
小叮当完成签到,获得积分10
3秒前
Meteor完成签到 ,获得积分10
3秒前
3秒前
setmefree发布了新的文献求助10
5秒前
6秒前
guo完成签到,获得积分20
7秒前
7秒前
L77的应助被daomaihu采纳,获得100
7秒前
L77的应助被daomaihu采纳,获得100
7秒前
Ttt完成签到,获得积分20
7秒前
完美世界的应助被赵彦婷采纳,获得10
8秒前
徐昊发布了新的文献求助10
8秒前
8秒前
8秒前
Maestro_S的应助被余莉莎采纳,获得10
8秒前
李爱国的应助被安静采纳,获得10
9秒前
9秒前
12121发布了新的文献求助10
9秒前
斯文的听南完成签到 ,获得积分10
10秒前
10秒前
10秒前
11秒前
你好发布了新的文献求助10
11秒前
11秒前
秋风的应助被义气的白凡采纳,获得30
11秒前
Hyuer发布了新的文献求助10
11秒前
guo发布了新的文献求助10
12秒前
12秒前
Ttt发布了新的文献求助10
12秒前
13秒前
14秒前
15秒前
Luckyhai完成签到,获得积分10
15秒前
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
RNA结合蛋白调控丝状真菌次级代谢的分子机制及功能研究 2000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1080
Encyclopedia of Modern Artificial Intelligence 1000
Особенности технологий и методов информационно-психологических войн СССР с Великобританией и США в период 1939-1953 гг 1000
Critical Psychology 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8145294
求助须知:如何正确求助?哪些是违规求助? 9544299
关于积分的说明 21661875
捐赠科研通 7731137
什么是DOI,文献DOI怎么找? 3422636
关于科研通互助平台的介绍 2547714
邀请新用户注册赠送积分活动 2465374